Aurealis Therapeutics

Aurealis Therapeutics company information, Employees & Contact Information

Updated May 2026

Quick answer

Aurealis Therapeutics is a Biotechnology Research company and founded in 2015. It has approximately 18 employees on record. Contact data was last refreshed in May 2026. Find Aurealis Therapeutics's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Aurealis Therapeutics is a Swiss-Finnish Cell and Gene Therapy Platform Company. Our multi-target cell and gene therapy platform, based on genetically modified safe lactic acid bacteria, addresses unmet medical needs: Chronic Wounds - Diabetic Foot Ulcers, Venous Ulcers, Pressure Ulcers - deadly Cancers - Ovarian Cancer, Peritoneal Carcinomatosis - Inflammation. After successfully completing our Phase 1 clinical study in Diabetic Foot Ulcer (DFU) patients with our lead clinical product AUP-16, our DFU Phase 2 study is ongoing in Italy, Germany and Poland. Venous Ulcers and other ulcers will follow. In Oncology, we are building on impressive pre-clinical data with Oncolytic Bacteria lead candidate AUP-55, which shows increased survival in Ovarian Cancer and peritoneal carcinomatosis. Our pipeline also includes Inflammation, at discovery stage.

Company Details

Employees
18
Founded
-
Address
Microkatu 1, Kuopio,70210,finland
Phone
358458433550
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Kuopio
Looking for a particular Aurealis Therapeutics employee's phone or email?

Aurealis Therapeutics Questions

Top Aurealis Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant